Michael S. Weiss - May 14, 2024 Form 4 Insider Report for Checkpoint Therapeutics, Inc. (CKPT)

Role
Director
Signature
/s/ James F. Oliviero, Attorney-in-Fact
Stock symbol
CKPT
Transactions as of
May 14, 2024
Transactions value $
$0
Form type
4
Date filed
5/16/2024, 07:35 PM
Previous filing
Jan 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CKPT COMMON STOCK Award $0 +32.1K +106.4% $0.00 62.2K May 14, 2024 See Note 3 F1, F2, F3
transaction CKPT COMMON STOCK Award $0 +50K +80.42% $0.00 112K May 14, 2024 See Note 3 F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The 32,051 shares of restricted Common Stock will vest on May 14, 2027, subject to Mr. Weiss's continued service on the board on such date.
F2 Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Weiss's continued service on the board.
F3 The shares are held by Hawkins BioVentures, LLC, of which Mr. Weiss is the sole member.
F4 The 50,000 shares of restricted Common Stock will vest according to the following schedule, subject to Mr. Weiss's continued service on the board on each date: one third on May 14, 2027, one third on May 14, 2028, and one third on May 14, 2029.